SCHEMBL5684191

SCHEMBL5684191

CC(N)(O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.53
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA5A P35218 1/20 0.49
CA9 Q16790 1/20 0.49
ALDH1A1 P00352 4/20 0.48
ACHE P22303 1/20 0.48
HSD17B10 Q99714 1/20 0.48
KDM4E B2RXH2 1/20 0.47
NOS1 P29475 2/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
POLB P06746 1/20 0.46
CES1 P23141 1/20 0.45
CYP19A1 P11511 1/20 0.45
PLAU P00749 1/20 0.44
HPGD P15428 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1023276 0.83 HSD11B1 (0.60) HSD11B1CA1CA2CA5ACA9
SCHEMBL3154297 0.83 ALDH1A1 (0.52) HSD11B1CA1CA2CA5ACA9
SCHEMBL12208260 0.83 HSD11B1 (0.56) HSD11B1CA1CA2CA5ACA9
SCHEMBL27579582 0.82 HSD11B1 (0.54) HSD11B1CA1CA2CA5ACA9
Hydrochloric Acid SCHEMBL3928206 0.82 ALDH1A1 (0.50) HSD11B1CA1CA2CA5ACA9
SCHEMBL27736519 0.80 HSD11B1 (0.61) HSD11B1CA1CA2CA5ACA9
SCHEMBL27539600 0.80 HSD11B1 (0.53) HSD11B1CA1CA2CA5ACA9
SCHEMBL10886554 0.79 TSHR (0.52) HSD11B1CA1CA2CA5ACA9
SCHEMBL5186052 0.79 HSD11B1 (0.49) HSD11B1CA1CA2CA5ACA9
SCHEMBL1648359 0.79 TDP1 (0.48) HSD11B1CA1CA2CA5ACA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620412-A2 HETEROCYCLIC COMPOUNDS AND HYDRO ISOMERS THEREOF Rigel Pharmaceuticals, Inc. (US) 2006-02-01 EP disclosed
WO-2004099165-A2 HETEROCYCLIC COMPOUNDS AND HYDRO ISOMERS THEREOF RIGEL PHARMACEUTICALS, INC. (US) 2004-11-18 WO disclosed